Anandarup Datta

Anandarup Datta has a diverse work experience in the pharmaceutical industry spanning over 20 years. Anandarup started their career at SUN PHARMA as a Chemist in FR&D in 2000. Anandarup then worked at Dr. Reddy's Laboratories as an Executive in FR&D for Generics from 2003 to 2004. Anandarup joined Aurobindo Pharma as a Research Associate in Formulation R&D for Generics from 2004 to 2006. Anandarup then worked at Ranbaxy Laboratories Ltd. as a Senior Research Scientist in Formulation for Generics from 2006 to 2007. Anandarup then returned to Dr. Reddy's Laboratories as a Manager in Formulation R&D for Generics, where they led a team responsible for filing and approval for the US and EU markets. Anandarup successfully closed more than 100 critical deficiency cases within a year. Anandarup then joined Amneal Pharmaceuticals as the HOD (Head of Department) for Formulation R&D from 2011 to 2013. There, they played a key role in setting up the R&D department and building a team for regulated market products. Following this, they worked at Laurus Labs as the Head of FR&D from 2013 to 2017. Anandarup'sresponsibilities included FR&D, Pkg R&D, T&T, and CPPK for generic formulation development. Anandarup was instrumental in setting up the R&D function and team for regulated market product development and accomplished the development of numerous products. In 2017, Anandarup joined Bliss GVS Pharma Ltd. as the Head of R&D. Further details regarding their role in this company are not provided.

Anandarup Datta holds a Bachelor of Pharmacy (B.Pharm.) degree in Pharmaceutical Technology from Jadavpur University. Anandarup later pursued a M Pharm degree in Pharmaceutical Technology from the same university. In 2014, they attended the National Institute of Bank Management (NIBM) and obtained an Executive Master of Business Administration (EMBA) degree.